AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+2.24%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.12B
AUM Growth
+$3.12B
(+40%)
Cap. Flow
+$814M
Cap. Flow
% of AUM
26.08%
Top 10 Holdings %
Top 10 Hldgs %
27.7%
Holding
147
New
41
Increased
50
Reduced
12
Closed
36
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.2M |
| 2 |
TJX Companies
TJX
|
$74.6M |
| 3 |
Amazon
AMZN
|
$61.6M |
| 4 |
Travere Therapeutics
TVTX
|
$58.8M |
| 5 |
Advance Auto Parts
AAP
|
$50.2M |
Top Sells
| 1 |
Lantheus
LNTH
|
$53.4M |
| 2 |
O'Reilly Automotive
ORLY
|
$41M |
| 3 |
Ulta Beauty
ULTA
|
$39.7M |
| 4 |
Five Below
FIVE
|
$38.4M |
| 5 |
Frontdoor
FTDR
|
$32.9M |
Sector Composition
| 1 | Healthcare | 65.24% |
| 2 | Consumer Staples | 14.09% |
| 3 | Consumer Discretionary | 13.47% |
| 4 | Technology | 3.01% |
| 5 | Industrials | 2.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $98.6M | 2.26% | 32,634,285 +2,500,000 | +8% | +$7.55M |
|
2
Bristol-Myers Squibb
BMY
$96B
| $94.7M | 2.17% | 1,500,000 +464,000 | +45% | +$29.3M |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $91.8M | 2.11% | 536,000 +264,000 | +97% | +$45.2M |
|
4
Supernus Pharmaceuticals
SUPN
$2.53B
| $89.3M | 2.05% | 3,412,000 +292,000 | +9% | +$7.64M |
|
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $84.2M | 1.93% | +392,000 | New | +$84.2M |
|
6
Incyte
INCY
$16.5B
| $83.9M | 1.93% | 1,032,000 +354,000 | +52% | +$28.8M |
|
7
Regeneron Pharmaceuticals
REGN
$61.5B
| $82.8M | 1.9% | 175,000 +43,000 | +33% | +$20.3M |
|
8
Enanta Pharmaceuticals
ENTA
$180M
| $81.3M | 1.87% | 1,648,000 +292,000 | +22% | +$14.4M |
|
9
Biogen
BIIB
$19.4B
| $80.6M | 1.85% | 288,000 +30,000 | +12% | +$8.39M |
|
|
10
Amazon
AMZN
$2.44T
| $77.4M | 1.78% | 25,000 +19,900 | +390% | +$61.6M |
|
|
11
TJX Companies
TJX
$152B
| $74.6M | 1.71% | +1,128,122 | New | +$74.6M |
|
|
BHVN
12
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $68.4M | 1.57% | 1,000,000 +428,000 | +75% | +$29.3M |
|
13
PTC Therapeutics
PTCT
$3.92B
| $66.1M | 1.52% | 1,396,000 +680,000 | +95% | +$32.2M |
|
14
Alkermes
ALKS
$4.78B
| $65.8M | 1.51% | 3,524,000 +1,308,000 | +59% | +$24.4M |
|
15
Medtronic
MDT
$119B
| $63.3M | 1.45% | 536,000 +280,000 | +109% | +$33.1M |
|
|
BLUE
16
DELISTED
bluebird bio
BLUE
| $59.2M | 1.36% | 1,964,000 +1,086,000 | +124% | +$32.7M |
|
|
17
Travere Therapeutics
TVTX
$1.56B
| $58.8M | 1.35% | +2,356,000 | New | +$58.8M |
|
|
18
Lantheus
LNTH
$3.73B
| $57.7M | 1.32% | 2,700,000 -2,500,000 | -48% | -$53.4M |
|
19
Walmart
WMT
$774B
| $57.4M | 1.32% | 422,268 +52,043 | +14% | +$7.07M |
|
20
Vanda Pharmaceuticals
VNDA
$279M
| $57M | 1.31% | 3,796,000 -1,603,277 | -30% | -$24.1M |
|
21
Zymeworks
ZYME
$1.12B
| $52.1M | 1.2% | 1,650,000 +1,200,000 | +267% | +$37.9M |
|
22
UnitedHealth
UNH
$281B
| $50.6M | 1.16% | 136,000 +36,000 | +36% | +$13.4M |
|
|
23
Advance Auto Parts
AAP
$3.66B
| $50.2M | 1.15% | +273,469 | New | +$50.2M |
|
24
Energizer
ENR
$1.88B
| $49.7M | 1.14% | 1,048,000 +70,000 | +7% | +$3.32M |
|
25
Coca-Cola
KO
$297B
| $48.3M | 1.11% | 916,000 +316,000 | +53% | +$16.7M |
|